Braintree Laboratories Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Braintree MA United States (1982)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
1999
NCT00164164
First Marketed Drug
1984
sodium chloride
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

BRAINTREE | Braintree Laboratories | Braintree Laboratories, Inc. | BRAINTREE LABS